Compare MRNA & RKLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRNA | RKLB |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | 2600 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6B | 41.3B |
| IPO Year | 2018 | 2020 |
| Metric | MRNA | RKLB |
|---|---|---|
| Price | $182.10 | $71.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 14 |
| Target Price | $34.27 | ★ $81.62 |
| AVG Volume (30 Days) | ★ 16.6M | 15.8M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.77 | 2.63 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,263,000,000.00 | $601,799,000.00 |
| Revenue This Year | $9.36 | $48.53 |
| Revenue Next Year | $15.43 | $39.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 4.29 | ★ 37.96 |
| 52 Week Low | $22.28 | $37.57 |
| 52 Week High | $176.86 | $150.85 |
| Indicator | MRNA | RKLB |
|---|---|---|
| Relative Strength Index (RSI) | 68.50 | 55.98 |
| Support Level | $46.85 | $64.94 |
| Resistance Level | $176.66 | $77.80 |
| Average True Range (ATR) | 9.39 | 3.07 |
| MACD | 0.06 | 1.23 |
| Stochastic Oscillator | 87.11 | 93.49 |
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, and rest of the world and earns key revenue from the United States.